D-amino acids as modulators of the genotoxic polyketide, colibactin.
D-amino acids as modulators of the genotoxic polyketide, colibactin.
批准号:
BB/W015781/1
负责人:
Andrew Roe
金额:
$61.11万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
“你吃什么就是什么”是每个人都应该接受的常用短语。例如,来自400多万患者的信息表明,肥胖、2型糖尿病和代谢健康状况差是导致COVID-19结果恶化的三个重要风险因素。这些风险因素受到我们所吃食物的严重影响。挑战在于我们的饮食是复杂的,很难知道什么对你来说是“好”或“坏”的。此外,人们越来越认识到我们的“肠道健康”的重要性,不同微生物的复杂混合有助于我们分解食物并防止有害细菌。许多人尝试用所谓的“好细菌”或益生菌补充他们的肠道微生物,这些益生菌声称提供,在某些情况下甚至显示出明显的积极影响。但是我们知道这些益生菌真的安全吗?最近的研究表明,E.大肠杆菌作为益生菌已经使用了近100年,实际上可以产生一种毒素,导致结肠直肠癌。这确实让我们担心。例如,肠癌是英国第三大最常见的癌症(占所有新发女性癌症病例的10%/所有新发男性癌症病例的13%),并且与饮食高度相关。一次偶然的机会,我们发现了一种简单的补充剂,可以帮助减少大肠杆菌毒素的产生。在实验室中培养的大肠杆菌。我们现在有3个重要的问题:(1)我们可以做更有效的补充,以阻止毒素。(2)补充剂如何影响毒素的产生和(3)它能在动物中起作用吗?这就是这项工作的三个目标。此外,我们的工作还旨在了解补充剂本身是否会影响肠道内的正常细菌。我们将通过观察治疗前后肠道中的不同物种来测试这一点。这是知道治疗本身不会引起问题的关键。
英文摘要
"You are what you eat" is a commonly used phrase that everyone should take on board. For example, information from over 4 million patients has shown that obesity, type 2 diabetes, and poor metabolic health are three significant risk factors for worse COVID-19 outcomes. These risk factors are heavily influenced by the food we eat. The challenge is that our diet is complex and it can be hard to know what is "good" or "bad" for you. Moreover, there is an increasing appreciation of the importance of our "gut health", the complex mix of different microbes that help us break down food and protect against harmful bacteria. Many people try and supplement their gut microbes with so called "good bacteria" or probiotics that claim to provide, and in some cases are even shown, to have clear positive impacts. But do we know these probiotics are actually safe? Recent work has shown that strains of E. coli that have been used for almost 100 years as probiotics, can actually produce a toxin that induces colo-rectal cancer. This is really worrying for us. For example, bowel cancer is the 3rd most common cancer (10% of all new female cancer cases/ 13% of all new male cancer cases) in the UK and highly related to diet. By chance, we have found a simple supplement that helps reduce the production of the toxin made by E. coli when it is grown in the lab. We now have 3 important questions: (1) can we make even more effective supplements to block the toxin. (2) how does the supplement affect toxin production and (3) can it work in animals? These are the three aims of this work. In addition, our work also aims to understand if the supplement itself affects the normal bacteria within the gut. We will test this by looking at the different species that live in the gut before and after the treatment. This is key to knowing that the treatment itself does not cause problems.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
A new twist on drug design: AdhE spirosomes as cross species anti-virulence targets
-
批准号:BB/V009494/1
-
项目类别:Research Grant
-
资助金额:$63.51万
-
财政年份:2021
-
负责人:Andrew Roe
-
依托单位:
Aversion Therapy for Bacteria: Repurposing Aurodox
-
批准号:MR/V011499/1
-
项目类别:Research Grant
-
资助金额:$79.06万
-
财政年份:2021
-
负责人:Andrew Roe
-
依托单位:
The Role of Dietary D-serine in Health and Disease
-
批准号:BB/R006539/1
-
项目类别:Research Grant
-
资助金额:$75.47万
-
财政年份:2018
-
负责人:Andrew Roe
-
依托单位:
Where and Why: The Influence of Host Metabolism on Bacterial Niche Specificity
-
批准号:BB/M029646/1
-
项目类别:Research Grant
-
资助金额:$56.07万
-
财政年份:2016
-
负责人:Andrew Roe
-
依托单位:
Utility of LOV-based Fluorescent Reporters To Monitor the Real-Time Secretion and Localisation of Bacterial Effector Proteins
-
批准号:BB/H023518/1
-
项目类别:Research Grant
-
资助金额:$12.32万
-
财政年份:2011
-
负责人:Andrew Roe
-
依托单位:
A biochemical and molecular analysis of the YhaO membrane protein in Escherichia coli O157:H7
-
批准号:BB/G011389/1
-
项目类别:Research Grant
-
资助金额:$52.3万
-
财政年份:2009
-
负责人:Andrew Roe
-
依托单位:
国内基金
海外基金
登录
查看更多内容
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
游离脂肪酸引起足细胞凋亡在早期糖尿病肾病微量白蛋白尿中的作用和机制探讨
-
批准号:30700373
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2007
-
负责人:陶建瓴
-
依托单位:
以胆酸为载体的肝靶向阿德福韦前体药物的研究
-
批准号:30772653
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2007
-
负责人:刘河
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: